Final results confirm and build on interim BIRCH results in 23 ICH patients Primary safety endpoint met with no mortality observedEncouraging efficacy signals on all clinical and biomarker endpoints ...

Transaction marks one of the first clinical-stage oncology acquisitions sourced, evaluated, and executed through an AI-powered drug development platformNEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- ...

Phase 3 wet AMD trials, LUGANO and LUCIA, remain on track with topline data expected beginning mid-2026 –Phase 3 DME clinical trials, COMO and ...

Damon Wayans has returned to stand-up comedy after nearly a decade, using humor to raise awareness about diabetic macular edema (DME), a vision-threatening complication of diabetes. Partnering with ...

New preclinical data presented demonstrate the candidates’ therapeutic potential as innovative treatments for retinal vascular diseases, such as DME and wAMD, providing potent and long-lasting ...

Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention ...

Event will feature Phase 1 clinical data for BGE-102 and the therapeutic rationale for development in atherosclerotic cardiovascular disease (ASCVD) and retinal disease Four leading academic and ...

Researchers examined the relationship between diabetic macular edema and the onset of neurodegenerative conditions in a ...

However, progression to more severe, vision-threatening forms of DRD showed a different epidemiologic picture, as the hazard ...

Eli Lilly stock dips after FAERS reports liver failure tied to obesity drug Foundayo (orforglipron). Read more here.

The comedian, a spokesperson for “GMA” sponsor Genentech, discusses the condition and its impact on communities of color.

The European Medicines Agency (EMA) has recommended granting pediatric use marketing authorization (PUMA) for Bopediat (furosemide, Proveca Pharma Limited) to treat children younger than 18 years with ...